{"nct_id":"NCT03379727","title":"Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.","status":"COMPLETED","status_verified_date":"2024-02","start_date":"2018-02-13","start_date_type":"ACTUAL","primary_completion_date":"2021-07-09","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}